Create your account

Analyse episodes, create alerts, spot trends before they go mainstream

Already have an account? Sign in

Companies

Pfizer

Mentioned in 80 analyzed podcast episodes across 10 shows

This multinational pharmaceutical company is a major developer of vaccines, including mRNA-based COVID-19 vaccines and pediatric immunizations, as well as treatments for migraine, weight loss, and other conditions. Podcasts discuss Pfizer's regulatory relationships, recent acquisitions (including Biohaven for $11.6 billion), pricing negotiations with government programs, and its pivot toward mRNA therapies for cancer and heart disease as vaccine demand declines. The company is also referenced in conversations about pharmaceutical industry practices, including pharmacy benefit manager rebates, marketing decisions, and research priorities.

Episode Mentions

Pharmaceutical Executive

Pharmaceutical Executive · May 13, 2026

Pharmaceutical Executive Daily: Rigel Pharmaceuticals Enters an Exclusive Global Licensing Agreement with Arvinas and Pfizer for Veppanu

Co-licensor of Vepanu with Arvinas; responsible for development, manufacturing, and commercialization

PROTAC Technology and Protein DegradationCancer Therapy InnovationGLP-1 Receptor Agonist Therapies
View Analysis
Pharma and BioTech Daily

Pharma and BioTech Daily · May 13, 2026

Pfizer's $85M Breast Cancer Deal & FDA Shakeup | Pharma and Biotech Daily

Leading $85M breast cancer therapy deal with Rigel Pharmaceuticals for Vepanu licensing with up to $320M milestone payments

FDA Leadership Transition and Regulatory StrategyPrecision Oncology and Targeted Breast Cancer TherapiesBiosimilar Competition and Market Erosion
View Analysis
99% Invisible

99% Invisible · May 12, 2026

Ask Your Doctor About

Mentioned as client of Brand Institute; developed Viagra with assistance from naming consultant David Wood

Pharmaceutical brand naming processes and methodologiesFDA drug name approval requirements and regulationsMedication error prevention through visual name differentiation
View Analysis
PBD Podcast

PBD Podcast · May 8, 2026

Hantavirus Lockdowns + Fauci's DOJ Deadline | PBD #794

Mentioned regarding vaccine documentation listing hantavirus as potential side effect on page 33 of 38-page document

Hantavirus Outbreak Response and CDC CredibilityUS-Iran Military Tensions and Ceasefire NegotiationsLA Mayoral Race: Karen Bass vs. Nithya Rahman vs. Spencer Pratt
View Analysis
The Biotech Startups Podcast

The Biotech Startups Podcast · May 7, 2026

🧬 Engineering a Drug Hunter: From Vet School to Big Pharma | Martin Brenner Rerelease (1/3)

One of several top global pharma companies where Martin led drug discovery teams during his career

AI-driven drug discovery platformsImmunotherapy development for difficult-to-treat cancersLeadership development in pharma and biotech
View Analysis
Deep Questions with Cal Newport

Deep Questions with Cal Newport · May 7, 2026

Is the AI Doom Fever Breaking? | AI Reality Check

Used as hypothetical comparison for how absurd it would be for pharma CEOs to terrify customers about their products

AI Job Displacement ClaimsExistential Risk (X-Risk) MovementAI CEO Communication Strategy
View Analysis
Schwab Market Update Audio

Schwab Market Update Audio · May 6, 2026

Jobs Data, Disney Awaited After New Record Highs

Up 1% despite profit decline, with investors forgiving 12% R&D spending increase for cancer and obesity products

AI Chip Competition and Market ConcentrationJobs Data and Labor Market StrengthSemiconductor Supply Chain Diversification
View Analysis
Pharma and BioTech Daily

Pharma and BioTech Daily · May 6, 2026

Sanofi Invests $294M in AI, FDA Approves Auvelity | Pharma and Biotech Daily

Discontinued Trillium Therapeutics acquisition ($2.3B) due to inadequate clinical results

AI Center of Excellence and Digital Transformation in Drug DevelopmentFDA Approval Processes and Regulatory ModernizationCAR-T Cell Therapy Expansion Beyond Oncology
View Analysis
On The Pen GLP-1 News

On The Pen GLP-1 News · May 5, 2026

He Took Retatrutide 40mg and Proved a Point

Abandoned denuglapron (small molecule GLP-1 pill) due to liver toxicity; earnings call discussed; danuglipron comparison mentioned

Gray market GLP-1 access and safety risksRetatrutide dosing errors and adverse eventsFoundae (orfoglutide) liver safety signals
View Analysis
Wall Street Breakfast

Wall Street Breakfast · May 5, 2026

Global borrowing costs soaring

Pharmaceutical company beat Q1 earnings estimates and reaffirmed full-year outlook, but shares remain down 35% over five years

Global Borrowing Costs and Bond YieldsCentral Bank Monetary Policy TighteningUK Government Gilt Yields
View Analysis
World Business Report

World Business Report · May 5, 2026

What's life like for seafarers stuck in the Strait of Hormuz?

Pharmaceutical company beat Q1 earnings expectations with $14.5B sales driven by blood thinners and cancer drugs

Strait of Hormuz shipping disruptionsUS-Iran military tensions and ceasefire fragilitySeafarer mental health and crew welfare
View Analysis
Pharma and BioTech Daily

Pharma and BioTech Daily · Apr 30, 2026

AstraZeneca's £300M UK Investment Resumes Amid FDA Pilot | Pharma and Biotech Daily

Elricks FIO showing promising results in multiple myeloma trials, reinforcing oncology market position

FDA Real-Time Clinical Trial Review PilotAstraZeneca UK Investment and Drug PricingOncology Market Consolidation Strategy
View Analysis
Pharma and BioTech Daily

Pharma and BioTech Daily · Apr 24, 2026

Regeneron Gene Therapy Approved by FDA: A Game-Changer! | Pharma and Biotech Daily

Halted next-generation cancer drug targeting PD-L1, reflecting complexities in oncology drug development

Gene Therapy Regulation and FDA Approval PathwaysHearing Loss Treatment InnovationGLP-1 Receptor Agonists for Type 2 Diabetes
View Analysis
The a16z Show

The a16z Show · Apr 23, 2026

Martin Shkreli on AI, Pharma, and What Actually Matters

Referenced as incumbent pharma company that DIY peptide users want to avoid; generic small molecules lose pricing power quickly

Photonic Computing and Optical HardwareAI Model Commoditization vs. Economic Value CaptureOpenAI vs. Anthropic Monetization Strategy
View Analysis
Squawk Pod

Squawk Pod · Apr 22, 2026

Gone Tripping: United CEO Scott Kirby & Psychedelic Therapy 4/22/26

Referenced as example of traditional pharmaceutical company with patent protection and pricing power models

Airline Industry Consolidation and Merger RegulationJet Fuel Price Volatility and Airline Pricing StrategyPsychedelic-Assisted Therapy Clinical Efficacy
View Analysis
Money Rehab with Nicole Lapin

Money Rehab with Nicole Lapin · Apr 22, 2026

The SpaceX IPO Is Coming. Here's Everything You Need To Know About IPO Risks and Rewards

Example of major company listed on NYSE; represents traditional exchange for non-tech companies.

IPO underpricing and first-day popsInstitutional vs. retail investor allocation in IPOsLockup period mechanics and post-expiration stock performance
View Analysis
unPAUSED with Dr. Mary Claire Haver

unPAUSED with Dr. Mary Claire Haver · Apr 21, 2026

Sexual Health, Libido, and Orgasm: What Medicine Missed with Dr. Kelly Casperson

Developed Viagra (1998), which catalyzed the creation of ISSWISH when women sought equivalent treatments

Female sexual desire and hypoactive sexual desire disorder (HSDD)Orgasm gap in heterosexual vs same-sex relationshipsResponsive vs spontaneous desire models
View Analysis
Bannon`s War Room

Bannon`s War Room · Apr 16, 2026

Episode 5306: Disbarment Of John Eastman; The Corporate Corruption Of Music

Pharmaceutical company referenced as example of corporate entity that cannot self-regulate

John Eastman Disbarment CaseFirst Amendment and Free Speech RightsInstitutional Capture and Marxist Influence
View Analysis
Scrolling with Hayley

Scrolling with Hayley · Apr 8, 2026

BEWARE of Female Predators! - Scrolling w/ Hayley (Ep. 273)

Discussed failed COVID vaccine trial unable to recruit 25,000 participants; now pursuing FDA approval for Lyme disease vaccine despite late-stage trial failure

Female Child Sexual Abuse in SchoolsChild Grooming and Predatory Behavior PatternsLaw Enforcement Training Gaps on Female Perpetrators
View Analysis
Mad Money w/ Jim Cramer

Mad Money w/ Jim Cramer · Apr 7, 2026

'Mad Money w/ Jim Cramer 4/7/26

Pharma company down 2.6%; sector weakness amid inflation concerns

Market Technical Analysis and Moving AveragesConsumer Spending Patterns and Economic SlowdownRetail Sector Performance and Competitive Dynamics
View Analysis
Human School

Human School · Apr 1, 2026

Dr. Jeffrey Balser: How Great Leaders Handle Hard Things

Developed COVID-19 vaccine; Vanderbilt's lab tested vaccine efficacy by analyzing patient serum samples

Leadership During Crisis ManagementOrganizational Culture and Hiring StrategyEmotional Intelligence and Resilience Training
View Analysis
CNBC's "Fast Money"

CNBC's "Fast Money" · Mar 31, 2026

Stocks Rally On Optimism For End Of Iran War… And Apple’s Mag-7 Outperformance 3/31/26

Shares hit highest levels since November 2024 on positive Lyme disease data and strong pipeline; up 13% year-to-date

Iran War Ceasefire Negotiations and Geopolitical RiskOil Price Dynamics and Energy IndependenceNike Earnings Miss and Athletic Wear Sector Weakness
View Analysis
TBPN

TBPN · Mar 23, 2026

The Great Peptide Debate with Martin Shkreli & Max Marchione

Major pharmaceutical company mentioned as part of the traditional drug industry Martin represents

Peptide regulation and FDA oversightBPC-157 safety and efficacy debateGLP-1 receptor agonists
View Analysis
Macroaggressions

Macroaggressions · Mar 20, 2026

Flashback Friday | #444: Chopping Down The Family Tree

Alleged involvement in depopulation agenda through vaccine development and mRNA technology platforms

National Security Memorandum 200 and Kissinger depopulation policyForced sterilization campaigns in Kenya, India, Bangladesh, and PeruWHO and UNICEF vaccine sterilization programs with HCG antigens
View Analysis
Cautionary Tales with Tim Harford

Cautionary Tales with Tim Harford · Mar 20, 2026

Presenting: Drug Story - On Xanax and Anxiety

Current owner of Upjohn's legacy products following corporate restructuring; inherited Xanax franchise and associated liability

Benzodiazepine Dependency and Withdrawal SyndromeXanax (Alprazolam) Abuse and CounterfeitingAnxiety Disorder Diagnosis and Classification
View Analysis
Bannon`s War Room

Bannon`s War Room · Mar 11, 2026

Episode 5207: SAVE America Act Vote Heads To The Senate; Majority Of America Supports Health Freedom

Pharmaceutical company; client of Fabrizio polling firm conducting allegedly biased vaccine polling

SAVE America Act - Voter ID and citizenship verification legislationElection Integrity - Voter roll audits and non-citizen votingAI Regulation - State-level AI Bill of Rights and safety frameworks
View Analysis
Bannon`s War Room

Bannon`s War Room · Mar 9, 2026

Episode 5202: President Trump Delivers Remarks To The Republican Members Conference

Mentioned as subject of potential legislative bundling with election security measures due to public sentiment

Election Security and Voter ID RequirementsIran Military Operations and Nuclear ThreatSave America Act Legislative Strategy
View Analysis
Brief Recess: A Legal Podcast with Michael Foote & Mélissa Malebranche

Brief Recess: A Legal Podcast with Michael Foote & Mélissa Malebranche · Mar 5, 2026

Technical Difficulties on Death Row (w. Corinna Barrett Lain)

Mentioned for refusing to allow its drugs (pentobarbital) to be used in executions despite being used for animal euthanasia and physician-assisted suicide

Lethal Injection Protocol Design and Scientific BasisProsecutorial Misconduct and Brady ViolationsDeath Penalty Exonerations and Innocence Rates
View Analysis
Adam Carolla Show

Adam Carolla Show · Mar 3, 2026

Why the Government Lied about COVID w/ Gavin de Becker

Manufacturer of COVID-19 vaccine; government-mandated product that didn't require traditional advertising due to state enforcement

COVID-19 Lockdown Policy EffectivenessGovernment Narrative Control and DisinformationVaccine Safety and Long-Term Testing Protocols
View Analysis
Danny Jones Podcast

Danny Jones Podcast · Feb 27, 2026

#374 - Ex-Pharma Insider Exposes the $368 Billion Health Insurance Scam | Brigham Buhler

Developed serotonin reuptake hypothesis questionnaire with APA; launched testosterone cream; created antidepressant market

Pharmacy Benefit Manager (PBM) Rebate Schemes and Price ManipulationInsurance Company Conflicts of Interest and Vertical IntegrationFDA Regulatory Capture and Revolving Door with Pharma
View Analysis
Macrodosing: Arian Foster and PFT Commenter

Macrodosing: Arian Foster and PFT Commenter · Feb 26, 2026

The Business of Cartels: Power, Politics, and Profit | Feb 26, 2026

Pharmaceutical company referenced in 'Love and Other Drugs' movie about pharma sales tactics

Mexican Drug Cartels and El Mencho's CaptureJalisco New Generation Cartel (CJNG) OperationsSinaloa Cartel and El Chapo's Imprisonment
View Analysis
Macroaggressions

Macroaggressions · Feb 25, 2026

#624: Bulls, Bears, & Birds

Pharmaceutical company represented at Bulls, Bears, and Birds to discuss vaccine supply during pandemic

Johns Hopkins Center for Civilian Biodefense Strategies and UPMC Center for Health Security institutional historyAvian influenza (H5N1) pandemic simulation and scenario planningFederal bioterrorism funding growth and industry creation (1998-2003)
View Analysis
Dr. Bob Martin Show

Dr. Bob Martin Show · Feb 24, 2026

Energy, Awareness, and the Hidden Heart

Discussed pivot from COVID vaccines to mRNA-based therapies for heart disease and cancer as vaccine demand wanes

Stress-Induced Heart FailureCortisol and Cardiovascular HealthHeart Rate Variability Monitoring
View Analysis
Dr. Bob Martin Show

Dr. Bob Martin Show · Feb 23, 2026

Recharge Your Body Battery: Small Choices, Big Shifts in Everyday Health

Discussed experimental oral weight loss drug showing 12.3% body weight reduction in mid-stage trials with investor enthusiasm

Weight Loss Pharmaceuticals and Metabolic HealthAutism Spectrum Disorder Diagnosis and Gender BiasCardiovascular Disease Prevention and Heart Health
View Analysis
Freakonomics Radio

Freakonomics Radio · Feb 20, 2026

664. Are Thousands of Medical Cures Hiding in Plain Sight?

Acquired Wyeth; developed pneumococcal vaccine as part of advanced market commitment program

Drug Repurposing EconomicsAdvanced Market CommitmentsFDA Regulatory Pathways
View Analysis
America At Night with McGraw Milhaven

America At Night with McGraw Milhaven · Feb 20, 2026

Andrew Eborn on Prince Andrew’s Arrest, Michael Rogers on GPS Threats, Brian Pinelli on Olympics

Mentioned as employer of baseball player who worked for company team while playing in Cape Cod League

Prince Andrew arrest and Epstein investigationGPS system vulnerabilities and national security threatsUK vs US legal and media standards for active cases
View Analysis
DarkHorse Podcast

DarkHorse Podcast · Feb 18, 2026

The History of Vaccine Hesitancy: Jeffrey Tucker on DarkHorse

Vaccine manufacturer discussed in context of liability indemnification and regulatory capture

Vaccine Industry Regulatory Capture and History (1776-2024)Intellectual Fragmentation Across Academic DisciplinesCOVID-19 Policy: Lockdowns, Mandates, and Civil Liberties
View Analysis
PBS News Hour - Full Show

PBS News Hour - Full Show · Feb 18, 2026

February 17, 2026 - PBS News Hour full episode

Mentioned as developer of mRNA COVID-19 vaccine alongside Moderna

mRNA Vaccine Development and FDA Approval ProcessChildhood Vaccination Recommendations Policy ChangesTrump Administration Health Policy and Robert F. Kennedy Jr. Influence
View Analysis
Marketplace

Marketplace · Feb 17, 2026

Why would the Fed loosen mortgage regulations?

Pharmaceutical company affected by changing vaccine regulatory environment and federal funding decisions

Federal Reserve Mortgage Regulation ReformBank Capital Requirements and Mortgage LendingNon-Bank Mortgage Origination Market Share
View Analysis
Marketplace All-in-One

Marketplace All-in-One · Feb 17, 2026

Why would the Fed loosen mortgage regulations?

Pharmaceutical company facing vaccine R&D headwinds from regulatory policy changes

Federal Reserve Mortgage Regulation ReformBank Capital Requirements and Mortgage LendingNon-Bank Fintech Competition in Mortgage Market
View Analysis
The a16z Show

The a16z Show · Feb 16, 2026

Novartis CEO Vasant Narasimhan on Transforming a 250-Year-Old Company

Announced partnership with Boltz Bio for AI-powered drug discovery platform

Corporate transformation and spin-offsCell and gene therapy platformsRNA therapeutics and siRNA technology
View Analysis
Relentless

Relentless · Feb 14, 2026

The Quest to Cure Alzheimer's | Sacha Schermerhorn, Babylon Bio

Acquired Biohaven for $11.6 billion for their migraine drug Nurtec

Alzheimer's Disease Drug DevelopmentTau Pathology and Neurofibrillary TanglesAmyloid Cascade Hypothesis
View Analysis
LONGEVITY with Nathalie Niddam

LONGEVITY with Nathalie Niddam · Feb 13, 2026

#412: From Anti-Aging to Age Reversal: The Exosome & Copper Peptide Breakthrough For Younger Skin With Debbi Barber and Dr. Jordan Plews

Dr. Jordan Plews worked in bioprocess development group before pursuing regenerative medicine research

Exosome sourcing and biological age of stem cellsStem cell exhaustion and agingCopper peptides (GHK-CU) and regenerative signaling
View Analysis
Culture Apothecary with Alex Clark

Culture Apothecary with Alex Clark · Feb 13, 2026

The Heart Disease Lie: It’s Not Genetic & Cholesterol Isn’t the Enemy | Dr. Jack Wolfson, DO

Lipitor (statin drug) generated $130+ billion in revenue; cited as example of pharmaceutical industry profitability

Statin drug efficacy and safety profileCholesterol's essential biological functionsGrass-fed vs. conventional meat nutritional differences
View Analysis
Throughline

Throughline · Feb 12, 2026

How Bad Bunny took Puerto Rican independence mainstream

Pharmaceutical manufacturer that shuttered Puerto Rico factories after Section 936 tax exemption ended in 1996, contributing to economic collapse.

Puerto Rican Colonial Status and U.S. Citizenship RightsSection 936 Tax Code Elimination and Economic CollapsePROMESA Fiscal Oversight Board and Austerity Policy
View Analysis
The Jesse Kelly Show

The Jesse Kelly Show · Feb 11, 2026

GOP Takes HUGE Step Toward Accountability in Jack Smith Arctic Frost Probe

Pharmaceutical company funding the American Academy of Pediatrics vaccine schedule decisions

Jack Smith Special Counsel Investigation and DOJ WeaponizationIllegal Immigrant Census Counting and Congressional ApportionmentTransgender Medical Procedures for Minors (SAFE Act)
View Analysis
The Daily

The Daily · Feb 11, 2026

TrumpRx Opens for Business

First major pharmaceutical company to negotiate TrumpRx deals; CEO appeared in press conference announcing discounted pricing on popular medications

Prescription Drug Pricing ReformHealthcare Affordability CrisisGLP-1 Obesity Medications Market
View Analysis
The Daily

The Daily · Feb 11, 2026

TrumpRx Opens for Business

First pharmaceutical company to announce pricing deal with Trump administration for TrumpRx website

Prescription drug pricingHealthcare affordabilityGovernment pharmaceutical negotiations
View Analysis
The Alex Jones Show - Infowars.com

The Alex Jones Show - Infowars.com · Feb 10, 2026

Alex Jones 2026-Feb-10 Tuesday

Mentioned as corporation protected by DOJ under Pam Bondi's pay-for-play arrangement

Epstein Files Content Analysis and RedactionsDemocratic Party Involvement in Child Trafficking NetworksTrump Administration DOJ Obstruction and Cover-up Strategy
View Analysis
unPAUSED with Dr. Mary Claire Haver

unPAUSED with Dr. Mary Claire Haver · Feb 10, 2026

Female Libido in Menopause: Desire Loss, Biology & Solutions with Cindy Eckert

Referenced as major pharma company that could have pursued female sexual health but didn't; developed Viagra (male sexual dysfunction treatment).

Female sexual desire disorder (HSDD) biology and neurotransmitter mechanismsFDA approval process and regulatory standards for women's sexual health medicationsPhysician education gaps in women's sexual health training
View Analysis